The report covers the dynamics of the GenAI market in China and highlights the key trends to watch for 2025, including agentic AI, GenAI at the edge, and embodied intelligence.
OM128253
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Generative AI in China – 2025: The Year Agentic AI Proliferates
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Universe: Chinese Commercial Foundation Model, 2024
Vendor Assessment / 13 Sep 2024 / Lian Jye Su
Through this Omdia Universe report, Omdia aims to suggest a holistic and objective approach to Chinese commercial foundation model benchmarking, helping enterprise users understand the market and choose the ideal solutions and vendors.
UPGRADE
Huawei Ushers In the Era of Autonomous IP Networks With GenAI
Analyst Opinion / 20 Dec 2024 / Lian Jye Su
In April 2024, Huawei officially launched a level four autonomous network solution for IP networks. The GenAI-based solution enhances IP network design, planning, operations, maintenance, and sustainability.
UPGRADE
Baidu leads the charge as agentic AI drives generative AI growth in Asia & Oceania
Analyst Opinion / 27 Nov 2024 / Lian Jye Su
Baidu has decided 2024 and beyond will be the year of generative AI (GenAI) applications and agentic AI as the company’s innovation (AgentBuilder and iRAG) and large user base will enable it to go head to head with its competitors.
UPGRADE
An error occured. Please try again later
You are now following this Analyst
You unfollowed this Analyst
The Analyst Team
Lian Jye Su
Follow AnalystChief Analyst
Lian Jye is a chief analyst at Omdia, responsible for the orchestration of applied intelligence market research in the Asia & Oceania region. He provides strategic guidance and business intelligence on AI infrastructure, software, and services. Lian Jye is widely quoted in the press and media on various AI- and robotics-related topics including on CNN, the BBC, CNBC, The Straits Times, and Nikkei Asian Review.
Prior to joining Omdia, Lian Jye worked in the research industry for nine years having started as a junior analyst covering cellular telecommunications technologies. In recent years, he has functioned as research director of AI and robotics, leading market intelligence services covering global market development and technological trends in robotics and AI hardware, software, and services. He graduated with a Bachelor of Science degree from the National University of Singapore and a Master of Business Administration from the University of Melbourne.
Become A Client
Find out more about our full suite of products and solutions.
Become A ClientYou must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Thank you
Our expert analysts will review your question and the Ask an Analyst team will get back to you. We aim to respond within 24 hours, but we’re often quicker.
Ask an Analyst
Our team of experts are here to answer your questions. From advice on market trends to a query on research point, and everything in between, we want to hear from you.
Ask an analyst is available as part of a subscription. If you'd like access, contact us today.